seed
Stage
2022
Founded
1
Investors
About
Polygon Therapeutics is a French biotech company specializing in cardio-immunology, developing immunotherapies to treat cardiovascular diseases by targeting the immune system's inflammatory pathways.
Explore Polygon Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.